Finance

Lists
SVNS:LON
Solvonis Therapeutics PLC
0,10 GBX
0,00%
(0,00) 1D
16 қаз., 16:35:14 GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for SVNS...
Open
0,10 GBX
High
0,10 GBX
Low
0,10 GBX
Mkt. cap
7,92 млн
Avg. vol.
25,35 млн
Volume
13,32 млн
52-wk high
0,39 GBX
52-wk low
0,10 GBX
EPS
-0,00 GBX
Shares outstanding
7,90 млрд
No. of employees
6
Open
0,10 GBX
High
0,10 GBX
Low
0,10 GBX
Mkt. cap
7,92 млн
Avg. vol.
25,35 млн
Volume
13,32 млн
52-wk high
0,39 GBX
52-wk low
0,10 GBX
EPS
-0,00 GBX
Shares outstanding
7,90 млрд
No. of employees
6
News stories
From web sources and news partners
About Solvonis Therapeutics PLC
CEO-
Employees6
Founded2017
Headquarters-
Sector-
Previous reportsAll values in GBP
Loading Previous Earnings...
Revenue
Net income
All values in GBP
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
213,00 м.
213,00 м.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
699,50 м.
699,50 м.
505,50 м.
505,50 м.
Operating expense
979,00 м.
979,00 м.
718,50 м.
718,50 м.
Total operating expenses
979,00 м.
979,00 м.
718,50 м.
718,50 м.
Operating income
-979,00 м.
-979,00 м.
-718,50 м.
-718,50 м.
Other non operating income
-
-
-
-
EBT including unusual items
-2,06 млн
-2,06 млн
-718,50 м.
-718,50 м.
EBT excluding unusual items
-928,00 м.
-928,00 м.
-718,50 м.
-718,50 м.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2,06 млн
-2,06 млн
-718,50 м.
-718,50 м.
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
2,00 мың
2,00 мың
-
-
Interest expense
-
-
-
-
Net interest expenses
2,00 мың
2,00 мың
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары